Revenue: The sum of all revenue fields included for a company's operating activities.
Prelude Therapeutics Incorporated (PRLD) had Revenue of $5.64M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
|
Revenue |
$5.64M |
$-16.46M |
|
-- |
|
$5.64M |
|
$22.99M |
|
$-17.35M |
|
$0.89M |
|
$-16.46M |
|
$-16.46M |
|
$-16.46M |
|
$-16.46M |
|
$-16.46M |
|
$-16.46M |
|
$-17.35M |
|
$-17.12M |
|
76.96M |
|
76.96M |
|
$-0.20 |
|
$-0.20 |
|
| Balance Sheet Financials | |
$105.69M |
|
$5.11M |
|
$35.62M |
|
$141.31M |
|
$52.99M |
|
-- |
|
$19.68M |
|
$72.68M |
|
$68.64M |
|
$68.64M |
|
$68.64M |
|
62.95M |
|
| Cash Flow Statement Financials | |
$-56.30M |
|
$53.46M |
|
$24.82M |
|
$16.52M |
|
$38.49M |
|
$21.97M |
|
$11.91M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.99 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-307.59% |
|
-307.59% |
|
-- |
|
-291.79% |
|
-291.79% |
|
$-56.37M |
|
-- |
|
-- |
|
-- |
|
0.04 |
|
-- |
|
-- |
|
-- |
|
-23.98% |
|
-23.98% |
|
-11.65% |
|
-23.98% |
|
$1.09 |
|
$-0.73 |
|
$-0.73 |
|